OABI Q2 2025 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-48.8% YoY

Gross Profit

$4M93.3% margin

Operating Income

-$16M-416.2% margin

Net Income

-$16M-407.4% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-6.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$296M

Total Liabilities

$34M

Stockholders' Equity

$262M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$8M	-48.8%
Gross Profit	$4M	$8M	-52.3%
Operating Income	-$16M	-$16M	+0.5%
Net Income	-$16M	-$14M	-16.5%

Revenue Segments

Service

$2M95%

Royalty

$111,0005%